Indications and recommendations for the use of recombinant human growth hormone in adult short bowel syndrome patients dependent on parenteral nutrition.

@article{Steiger2006IndicationsAR,
  title={Indications and recommendations for the use of recombinant human growth hormone in adult short bowel syndrome patients dependent on parenteral nutrition.},
  author={Ezra Steiger and John K. Dibaise and Bernard Messing and Laura E. Matarese and Sandra Blethen},
  journal={Journal of clinical gastroenterology},
  year={2006},
  volume={40 Suppl 2},
  pages={S99-106}
}
Given the lack of published guidelines regarding the use of trophic factors to treat patients with short bowel syndrome (SBS), a group of experts in the field convened to discuss best-practice strategies. Trophic factors, such as recombinant human growth hormone (r-hGH) and glucagon-like peptide-2 (GLP-2), may enhance intestinal adaptation and decrease parenteral nutrition (PN) requirements; therefore, their utility in treating SBS patients was evaluated. Available clinical data on use of r-hGH… CONTINUE READING